Market closed

Atara Biotherapeutics/$ATRA

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Atara Biotherapeutics

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Ticker

$ATRA
Trading on

Industry

Biotechnology

Employees

159

ATRA Metrics

BasicAdvanced
$66M
Market cap
-
P/E ratio
-$22.60
EPS
0.49
Beta
-
Dividend rate
$66M
0.49
$39.50
$6.50
102K
0.589
0.439
-38.926
-55.115
-12.90%
-45.03%
188.38%
0.669
-0.72
-0.72
-0.708
2,111.34%
-67.40%
98.76%
-37.02%

What the Analysts think about ATRA

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Atara Biotherapeutics stock.

ATRA Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ATRA Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ATRA

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Atara Biotherapeutics stock?

Atara Biotherapeutics (ATRA) has a market cap of $66M as of December 24, 2024.

What is the P/E ratio for Atara Biotherapeutics stock?

The price to earnings (P/E) ratio for Atara Biotherapeutics (ATRA) stock is 0 as of December 24, 2024.

Does Atara Biotherapeutics stock pay dividends?

No, Atara Biotherapeutics (ATRA) stock does not pay dividends to its shareholders as of December 24, 2024.

When is the next Atara Biotherapeutics dividend payment date?

Atara Biotherapeutics (ATRA) stock does not pay dividends to its shareholders.

What is the beta indicator for Atara Biotherapeutics?

Atara Biotherapeutics (ATRA) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.